GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen Marseille SA (STU:IPK) » Definitions » Beneish M-Score

Qiagen Marseille (STU:IPK) Beneish M-Score : 0.00 (As of Jun. 17, 2025)


View and export this data going back to . Start your Free Trial

What is Qiagen Marseille Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Qiagen Marseille's Beneish M-Score or its related term are showing as below:

During the past 7 years, the highest Beneish M-Score of Qiagen Marseille was 0.00. The lowest was -0.93. And the median was -0.93.


Qiagen Marseille Beneish M-Score Historical Data

The historical data trend for Qiagen Marseille's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen Marseille Beneish M-Score Chart

Qiagen Marseille Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Beneish M-Score
Get a 7-Day Free Trial - - -0.93 - -

Qiagen Marseille Semi-Annual Data
Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.93 - - - -

Competitive Comparison of Qiagen Marseille's Beneish M-Score

For the Diagnostics & Research subindustry, Qiagen Marseille's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen Marseille's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen Marseille's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Qiagen Marseille's Beneish M-Score falls into.


;
;

Qiagen Marseille Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Qiagen Marseille for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.3381+0.528 * 0.9325+0.404 * 1.2028+0.892 * 1.2124+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1156+4.679 * -0.131238-0.327 * 0.5064
=-3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec14) TTM:Last Year (Dec13) TTM:
Total Receivables was €3.18 Mil.
Revenue was €18.00 Mil.
Gross Profit was €11.83 Mil.
Total Current Assets was €19.73 Mil.
Total Assets was €37.99 Mil.
Property, Plant and Equipment(Net PPE) was €0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.00 Mil.
Selling, General, & Admin. Expense(SGA) was €1.48 Mil.
Total Current Liabilities was €3.42 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Net Income was €6.15 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €11.13 Mil.
Total Receivables was €7.76 Mil.
Revenue was €14.85 Mil.
Gross Profit was €9.10 Mil.
Total Current Assets was €16.64 Mil.
Total Assets was €30.73 Mil.
Property, Plant and Equipment(Net PPE) was €1.81 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.00 Mil.
Selling, General, & Admin. Expense(SGA) was €1.10 Mil.
Total Current Liabilities was €5.30 Mil.
Long-Term Debt & Capital Lease Obligation was €0.16 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3.182 / 18.001) / (7.764 / 14.848)
=0.176768 / 0.522899
=0.3381

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9.102 / 14.848) / (11.834 / 18.001)
=0.613012 / 0.657408
=0.9325

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (19.73 + 0) / 37.992) / (1 - (16.64 + 1.806) / 30.725)
=0.48068 / 0.399642
=1.2028

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=18.001 / 14.848
=1.2124

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1.806)) / (0 / (0 + 0))
=0 /
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.481 / 18.001) / (1.095 / 14.848)
=0.082273 / 0.073747
=1.1156

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 3.417) / 37.992) / ((0.162 + 5.295) / 30.725)
=0.08994 / 0.177608
=0.5064

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(6.145 - 0 - 11.131) / 37.992
=-0.131238

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Qiagen Marseille has a M-score of -3.33 suggests that the company is unlikely to be a manipulator.


Qiagen Marseille Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Qiagen Marseille's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen Marseille Business Description

Traded in Other Exchanges
N/A
Address
Qiagen Marseille SA develops molecular diagnostic tests designed to map diseases in order to guide patients and oncologists decisions along their complex therapeutic path.

Qiagen Marseille Headlines

No Headlines